This HTML5 document contains 141 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-dehttp://de.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n19https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n20http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:MERS
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:MVA-B
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:MVA85A
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Non-replicating_smallpox_vaccine
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
dbo:wikiPageRedirects
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Bavarian_Nordic
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Marylyn_Addo
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:GeoVax
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Modified_vaccinia_Ankara
rdf:type
yago:Object100002684 yago:AnimalVirus101335659 yago:LivingThing100004258 yago:WikicatGeneticallyModifiedOrganisms dbo:Drug yago:Agent109190918 yago:Microorganism101326291 yago:Whole100003553 yago:InfectiousAgent109312843 yago:Antigen115037339 owl:Thing yago:WikicatPoxviruses yago:PhysicalEntity100001930 wikidata:Q8386 yago:Immunogen103562739 dbo:Vaccine yago:Virus101328702 yago:Matter100020827 yago:Poxvirus101333731 yago:Organism100004475 yago:Substance100020090 yago:WikicatVaccines dbo:ChemicalSubstance yago:CausalAgent100007347 yago:Vaccine104517535 n20:ChemicalObject
rdfs:label
Modified-Vaccinia-Ankara-Virus Modified vaccinia Ankara
rdfs:comment
Das Modified-Vaccinia-Ankara-Virus (MVA) ist ein abgeschwächtes (genauer: attenuiertes) Kuhpockenvirus, das zu Impfzwecken verwendet wird. Modified vaccinia Ankara (MVA) is an attenuated (weakened) strain of the vaccinia virus. It is being used as a vaccine (called MVA-BN, brand names: Imvanex in the EU, Imvamune in Canada, and Jynneos in the US) against smallpox and monkeypox, having fewer side effects than the traditional smallpox vaccine. This third-generation smallpox vaccine has the advantage that it cannot reproduce complete virions in human cells, "the block of the MVA life cycle occurs at the step of virion assembly resulting in assembly of immature virus particles that are not released from the infected cell."
dcterms:subject
dbc:Products_introduced_in_1968 dbc:German_inventions dbc:1968_in_biology dbc:Genetically_modified_organisms dbc:Vaccines dbc:1968_establishments_in_West_Germany dbc:Vaccinia
dbo:wikiPageID
2257802
dbo:wikiPageRevisionID
1124050825
dbo:wikiPageWikiLink
dbr:Smallpox_vaccine dbr:Cancer dbc:Products_introduced_in_1968 dbr:HIV_infection dbr:Genes dbr:Transgene dbr:Vectors_in_gene_therapy dbr:Bavarian_Nordic dbr:MVA-B dbr:Gene_expression dbr:MVA85A dbr:Subcutaneous_injection dbr:Reporter_gene dbr:Ankara dbr:Serial_passage dbr:Emergency_use_authorization dbr:Fibroblast dbr:Smallpox dbr:Orthopoxvirus dbc:1968_in_biology dbr:Monkeypox dbc:Vaccines dbc:1968_establishments_in_West_Germany dbr:Flaviviruses dbr:Vaccine dbr:Food_and_Drug_Administration dbc:Genetically_modified_organisms dbr:Antigens dbr:Influenza dbr:Poxvirus dbc:Vaccinia dbr:Intradermal_injection dbr:Vaccinia dbr:Antigen dbr:Measles dbr:Plasmodium dbr:Parainfluenza dbr:Genetic_recombination dbr:Centers_for_Disease_Control_and_Prevention dbc:German_inventions dbr:Viral_vector_vaccine
owl:sameAs
freebase:m.06zt7q wikidata:Q6889412 yago-res:Modified_vaccinia_Ankara dbpedia-de:Modified-Vaccinia-Ankara-Virus n19:4rpvR
dbp:vaccineType
attenuated
dbp:wikiPageUsesTemplate
dbt:2022_monkeypox_outbreak dbt:Reflist dbt:Infobox_drug dbt:Use_dmy_dates dbt:Drugs.com dbt:Cite_journal
dbp:atcSuffix
BX
dbp:atcPrefix
J07
dbp:chemspiderid
none
dbp:legalUk
POM
dbp:legalUs
Rx-only
dbp:routesOfAdministration
dbr:Subcutaneous_injection dbr:Intradermal_injection
dbp:synonyms
MVA
dbp:target
dbr:Smallpox dbr:Monkeypox
dbp:tradename
Imvanex, Imvamune, Jynneos
dbp:type
vaccine
dbo:abstract
Das Modified-Vaccinia-Ankara-Virus (MVA) ist ein abgeschwächtes (genauer: attenuiertes) Kuhpockenvirus, das zu Impfzwecken verwendet wird. Modified vaccinia Ankara (MVA) is an attenuated (weakened) strain of the vaccinia virus. It is being used as a vaccine (called MVA-BN, brand names: Imvanex in the EU, Imvamune in Canada, and Jynneos in the US) against smallpox and monkeypox, having fewer side effects than the traditional smallpox vaccine. This third-generation smallpox vaccine has the advantage that it cannot reproduce complete virions in human cells, "the block of the MVA life cycle occurs at the step of virion assembly resulting in assembly of immature virus particles that are not released from the infected cell." By inserting antigen genes into its genome, modified vaccinia Ankara virus is also used as an experimental viral vector for vaccines against non-poxvirus diseases.
dbp:legalCa
Rx-only, Schedule D
dbp:legalEu
Rx-only
gold:hypernym
dbr:Vaccine
prov:wasDerivedFrom
wikipedia-en:Modified_vaccinia_Ankara?oldid=1124050825&ns=0
dbo:wikiPageLength
15648
dbo:alternativeName
Imvanex, Imvamune, Jynneos
foaf:isPrimaryTopicOf
wikipedia-en:Modified_vaccinia_Ankara
Subject Item
dbr:Monkeypox
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Orthopoxvirus
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Smallpox_vaccine
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:COVID-19_vaccine
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:2022_monkeypox_outbreak
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:2022_monkeypox_outbreak_in_Germany
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:2022_monkeypox_outbreak_in_the_United_States
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Adrian_V._S._Hill
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Ebola_vaccine
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:COH04S1
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:ChAdOx1
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:MVA
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
dbo:wikiPageDisambiguates
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Vaccinia
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Modified_Vaccinia_Ankara
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
dbo:wikiPageRedirects
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Viral_vector_vaccine
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
Subject Item
dbr:Modified_Vaccinia_Ankara_Virus
dbo:wikiPageWikiLink
dbr:Modified_vaccinia_Ankara
dbo:wikiPageRedirects
dbr:Modified_vaccinia_Ankara
Subject Item
wikipedia-en:Modified_vaccinia_Ankara
foaf:primaryTopic
dbr:Modified_vaccinia_Ankara